Zobrazeno 1 - 10
of 2 019
pro vyhledávání: '"Zanda, M"'
Autor:
Griffiths K; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK., Grand RJ; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Horan I; Department for Medicine, University of Cambridge, Cambridge, UK., Certo M; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK., Keeler RC; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK., Mauro C; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK., Tseng CC; Kosterlitz Centre for Therapeutics, University of Aberdeen, Aberdeen, UK., Greig I; Kosterlitz Centre for Therapeutics, University of Aberdeen, Aberdeen, UK., Morrell NW; Department for Medicine, University of Cambridge, Cambridge, UK., Zanda M; The Institute of Chemical Sciences and Technologies, Milan, Italy., Frenneaux MP; Academic Health System, Hamad Medical Corporation, Doha, Qatar., Madhani M; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. Electronic address: m.madhani@bham.ac.uk.
Publikováno v:
Vascular pharmacology [Vascul Pharmacol] 2024 Sep; Vol. 156, pp. 107399. Date of Electronic Publication: 2024 Jun 18.
Autor:
Thompson KJ; Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK., Watson S; Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK., Zanato C; Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK., Dall'Angelo S; Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK., De Nooij JC; Department of Neurology, Columbia University, New York, NY, USA., Pace-Bonello B; Department of Biosciences, Durham University, Durham, UK., Shenton FC; Department of Biosciences, Durham University, Durham, UK., Sanger HE; Eli Lilly, Bracknell, UK., Heinz BA; Eli Lilly, Bracknell, UK., Broad LM; Eli Lilly, Bracknell, UK., Grosjean N; CNRS UMR 5297, Interdisciplinary Institute of Neuroscience, University of Bordeaux, Bordeaux, France., McQuillian JR; Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK., Dubini M; Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK., Pyner S; Department of Biosciences, Durham University, Durham, UK., Greig I; Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK., Zanda M; Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK., Bleakman D; Eli Lilly, Bracknell, UK., Banks RW; Department of Biosciences, Durham University, Durham, UK., Bewick GS; Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK.
Publikováno v:
Experimental physiology [Exp Physiol] 2024 Jan; Vol. 109 (1), pp. 81-99. Date of Electronic Publication: 2023 Sep 01.
Publikováno v:
In Information Processing and Management July 2014 50(4):584-598
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Patruno I., Thomson D., Mody N., Windhorst A. D., Poot A. J., Vugts D. J., Dall'Angelo S., Zanda M.
Publikováno v:
Poster at EMIM 2019
Fenretinide (4-HPR) is a synthetic retinoid which has been investigated for decades as an anticancer agent and more recently as a potential drug to treat metabolic syndrome. Here we synthesised a library of 4-HPR analogues - using a SAR approach - wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ff75f307e7a62868b7cc6dfc0abf945e
https://doi.org/10.5281/zenodo.3952481
https://doi.org/10.5281/zenodo.3952481
Autor:
Zanda, M T1, Fadda, P1, Antinori, S1, Di Chio, M2, Fratta, W1, Chiamulera, C2, Fattore, L3 lfattore@in.cnr.it
Publikováno v:
British Journal of Pharmacology. Oct2017, Vol. 174 Issue 19, p3333-3345. 13p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Salvatore D; Cystic Fibrosis Centre, Hospital San Carlo, Potenza, Italy., Cimino G; Lazio Reference Centre for Cystic Fibrosis, Policlinico Umberto I University Hospital, Rome, Italy., Troiani P; Lazio Reference Centre for Cystic Fibrosis, Policlinico Umberto I University Hospital, Rome, Italy., Bignamini E; Pediatric Pulmonology Unit, Città della Salute e della Scienza, Ospedale Infantile Regina Margherita, Turin, Italy., Esposito I; Pediatric Pulmonology Unit, Città della Salute e della Scienza, Ospedale Infantile Regina Margherita, Turin, Italy., Leonetti G; Pediatric Cystic Fibrosis Centre, Azienda Universitaria Ospedaliera Consorziale Policlinico, Bari, Italy., Zanda M; Cystic Fibrosis Center, Azienda Ospedaliera Brotzu, Cagliari, Italy., Manunza D; Cystic Fibrosis Center, Azienda Ospedaliera Brotzu, Cagliari, Italy., Pepe A; Cystic Fibrosis Centre, Hospital San Carlo, Potenza, Italy.; Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, Postgraduate School of Pediatrics, University of Salerno, Baronissi, Italy.
Publikováno v:
Pediatric pulmonology [Pediatr Pulmonol] 2022 Sep; Vol. 57 (9), pp. 2253-2256. Date of Electronic Publication: 2022 May 25.
Publikováno v:
Hypoxia, Vol Volume 5, Pp 45-59 (2017)
Paolo Lazzari,1 Marco Spiga,1 Monica Sani,1,2 Matteo Zanda,2,3 Ian N Fleming4 1KemoTech s.r.l., Parco Scientifico della Sardegna, Pula, Cagliari, 2C.N.R. – Istituto di Chimica del Riconoscimento Molecolare, Sezione ‘A. Quilico’, Milano, Italy;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::094d6454f722638911ef4e62bf7dabd0
https://www.dovepress.com/kemtub012-ni2-a-novel-potent-tubulysin-analog-that-selectively-targets-peer-reviewed-article-HP
https://www.dovepress.com/kemtub012-ni2-a-novel-potent-tubulysin-analog-that-selectively-targets-peer-reviewed-article-HP
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.